Cargando…

Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression

BACKGROUND: Oncogenic Human Papillomaviruses (HPVs) base their transforming potential on the action of both E6 and E7 viral oncoproteins, which perform cooperative or antagonistic actions and thus interfere with a variety of relevant cellular targets. Among them, the expression of some PDZ-containin...

Descripción completa

Detalles Bibliográficos
Autores principales: Dizanzo, María Paula, Bugnon Valdano, Marina, Basukala, Om, Banks, Lawrence, Gardiol, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509620/
https://www.ncbi.nlm.nih.gov/pubmed/36153517
http://dx.doi.org/10.1186/s12885-022-10105-5
_version_ 1784797266970673152
author Dizanzo, María Paula
Bugnon Valdano, Marina
Basukala, Om
Banks, Lawrence
Gardiol, Daniela
author_facet Dizanzo, María Paula
Bugnon Valdano, Marina
Basukala, Om
Banks, Lawrence
Gardiol, Daniela
author_sort Dizanzo, María Paula
collection PubMed
description BACKGROUND: Oncogenic Human Papillomaviruses (HPVs) base their transforming potential on the action of both E6 and E7 viral oncoproteins, which perform cooperative or antagonistic actions and thus interfere with a variety of relevant cellular targets. Among them, the expression of some PDZ-containing polarity proteins, as DLG1 and hScrib, is altered during the HPV life cycle and the consequent malignant transformation. Together with the well-established interference of E6 with PDZ proteins, we have recently shown that E7 viral oncoprotein is also responsible for the changes in abundance and localization of DLG1 observed in HPV-associated lesions. Given that the mechanisms involved remained only partially understood, we here thoroughly analyse the contribution of a crucial E7 post-translational modification: its CKII-dependent phosphorylation. Moreover, we extended our studies to hScrib, in order to investigate possible conserved regulatory events among diverse PDZ targets of HPV. METHODS: We have acutely analysed the expression of DLG1 and hScrib in restrictive conditions for E7 phosphorylation by CKII in epithelial culture cells by western blot and confocal fluorescence microscopy. We made use of genome-edited HPV-positive cells, specific inhibitors of CKII activity and transient expression of the viral oncoproteins, including a mutant version of E7. RESULTS: We here demonstrate that the functional phosphorylation of E7 oncoprotein by the CKII cellular kinase, a key regulatory event for its activities, is also crucial to counteract the E6-mediated degradation of the PDZ-polarity protein DLG1 and to promote its subcellular redistribution. Moreover, we show that the CKII-dependent phosphorylation of E7 is able to control the expression of another PDZ target of HPV: hScrib. Remarkably, we found this is a shared feature among different oncogenic HPV types, suggesting a common path towards viral pathogenesis. CONCLUSIONS: The present study sheds light into the mechanisms behind the misexpression of PDZ-polarity proteins during HPV infections. Our findings stress the relevance of the CKII-mediated regulation of E7 activities, providing novel insights into the joint action of HPV oncoproteins and further indicating a conserved and most likely crucial mechanism during the viral life cycle and the associated transformation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10105-5.
format Online
Article
Text
id pubmed-9509620
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95096202022-09-26 Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression Dizanzo, María Paula Bugnon Valdano, Marina Basukala, Om Banks, Lawrence Gardiol, Daniela BMC Cancer Research BACKGROUND: Oncogenic Human Papillomaviruses (HPVs) base their transforming potential on the action of both E6 and E7 viral oncoproteins, which perform cooperative or antagonistic actions and thus interfere with a variety of relevant cellular targets. Among them, the expression of some PDZ-containing polarity proteins, as DLG1 and hScrib, is altered during the HPV life cycle and the consequent malignant transformation. Together with the well-established interference of E6 with PDZ proteins, we have recently shown that E7 viral oncoprotein is also responsible for the changes in abundance and localization of DLG1 observed in HPV-associated lesions. Given that the mechanisms involved remained only partially understood, we here thoroughly analyse the contribution of a crucial E7 post-translational modification: its CKII-dependent phosphorylation. Moreover, we extended our studies to hScrib, in order to investigate possible conserved regulatory events among diverse PDZ targets of HPV. METHODS: We have acutely analysed the expression of DLG1 and hScrib in restrictive conditions for E7 phosphorylation by CKII in epithelial culture cells by western blot and confocal fluorescence microscopy. We made use of genome-edited HPV-positive cells, specific inhibitors of CKII activity and transient expression of the viral oncoproteins, including a mutant version of E7. RESULTS: We here demonstrate that the functional phosphorylation of E7 oncoprotein by the CKII cellular kinase, a key regulatory event for its activities, is also crucial to counteract the E6-mediated degradation of the PDZ-polarity protein DLG1 and to promote its subcellular redistribution. Moreover, we show that the CKII-dependent phosphorylation of E7 is able to control the expression of another PDZ target of HPV: hScrib. Remarkably, we found this is a shared feature among different oncogenic HPV types, suggesting a common path towards viral pathogenesis. CONCLUSIONS: The present study sheds light into the mechanisms behind the misexpression of PDZ-polarity proteins during HPV infections. Our findings stress the relevance of the CKII-mediated regulation of E7 activities, providing novel insights into the joint action of HPV oncoproteins and further indicating a conserved and most likely crucial mechanism during the viral life cycle and the associated transformation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10105-5. BioMed Central 2022-09-25 /pmc/articles/PMC9509620/ /pubmed/36153517 http://dx.doi.org/10.1186/s12885-022-10105-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Dizanzo, María Paula
Bugnon Valdano, Marina
Basukala, Om
Banks, Lawrence
Gardiol, Daniela
Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression
title Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression
title_full Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression
title_fullStr Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression
title_full_unstemmed Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression
title_short Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression
title_sort novel effect of the high risk-hpv e7 ckii phospho-acceptor site on polarity protein expression
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509620/
https://www.ncbi.nlm.nih.gov/pubmed/36153517
http://dx.doi.org/10.1186/s12885-022-10105-5
work_keys_str_mv AT dizanzomariapaula noveleffectofthehighriskhpve7ckiiphosphoacceptorsiteonpolarityproteinexpression
AT bugnonvaldanomarina noveleffectofthehighriskhpve7ckiiphosphoacceptorsiteonpolarityproteinexpression
AT basukalaom noveleffectofthehighriskhpve7ckiiphosphoacceptorsiteonpolarityproteinexpression
AT bankslawrence noveleffectofthehighriskhpve7ckiiphosphoacceptorsiteonpolarityproteinexpression
AT gardioldaniela noveleffectofthehighriskhpve7ckiiphosphoacceptorsiteonpolarityproteinexpression